Rapid discovery of monoclonal antibodies via high-throughput single BCR affinity sequencing
Nucleic Acids Research · 10.08.2026 · 54 (15)
DOI: 10.1093/nar/gkag789 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nucleic Acids Research, online erschienen am 20.08.2026. Verfasst von Mengzhu Hu und 11 weiteren Autor:innen. Beteiligte Einrichtung: Single Cell Systems Biology Laboratory, College of Marine Life Sciences, Ocean University of China, Qingdao, Shandong 266100, China. Hauptthemen laut MEDLINE: Antibodies, Monoclonal, High-Throughput Nucleotide Sequencing, Antibody Affinity. Die Arbeit nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: STI2030-Major Projects, Lingang Laboratory Grant LGL-8888, GuangDong Basic and Applied Basic Research Foundation.
Abstract (Originalsprache)
To jointly capture antigen-binding affinity and paired heavy–light-chain sequences at scale has remained a bottleneck for monoclonal antibody discovery. Here, we present Antigen Affinity BCR-seq (AAB-seq), a high-throughput single-cell sequencing platform that can obtain the relative antibody–antigen affinity of thousands of paired native BCR sequences. AAB-seq employs dual-labeled antigens and DNA-barcoded anti-light-chain antibodies to compute an AAB score that is proportional to antibody–antigen binding strength. Integrated with a rapid, low-cost direct cloning workflow, it enables affinity-guided antibody retrieval without de novo antibody gene synthesis. Validated against ovalbumin and SARS–COV–2 RBD, AAB-seq discovered potent antibodies whose AAB score correlates strongly with ELISA, including novel SARS–COV–2 neutralizing antibodies with potent effector functions. Together, AAB-seq accelerates antibody screening and potentially provides large-scale sequence-affinity datasets for machine learning-driven therapeutic antibody design and development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Single Cell Systems Biology Laboratory, College of Marine Life Sciences, Ocean University of China, Qingdao, Shandong 266100, China.
- Gurdon Institute, Tennis Court Road, University of Cambridge, Cambridge CB2 1QN, United Kingdom.
- Department of Applied Mathematics and Theoretical Physics, Centre for Mathematical Sciences, University of Cambridge, Cambridge CB3 0WA, United Kingdom.
- State Key Laboratory of Microbial Technology, Shandong University, Qingdao 266237, China.
- Department of Orthopedics, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200092, China.
- Institute of Translational Medicine, Shanghai University, Shanghai 200444, China.
ORCID-Profile: Mengzhu Hu, Mengge Huang, Jiacan Su
Förderung
- STI2030-Major Projects
- Lingang Laboratory Grant LGL-8888
- GuangDong Basic and Applied Basic Research Foundation
- Science-Medicine interdisciplinary
- Natural Science Foundation of China
- China Postdoctoral Science Foundation
- Shandong Provincial Postdoctoral Innovation Project
Zitieren
APA
Hu, M., Lian, Q., Cui, X., Chen, X., Dong, X., Huang, M., Wang, G., Hu, Y., Zhang, H., Su, J., Xin, H., & Shi, W. (2026). Rapid discovery of monoclonal antibodies via high-throughput single BCR affinity sequencing. Nucleic Acids Research, 54(15). https://doi.org/10.1093/nar/gkag789
Vancouver
Hu M, Lian Q, Cui X, Chen X, Dong X, Huang M, et al. Rapid discovery of monoclonal antibodies via high-throughput single BCR affinity sequencing. Nucleic Acids Research. 2026;54(15). doi:10.1093/nar/gkag789
BibTeX
@article{Hu2026,
author = {Hu, Mengzhu and Lian, Qiuyu and Cui, Xiaonan and Chen, Xiao and Dong, Xue and Huang, Mengge and Wang, Guangchao and Hu, Yan and Zhang, Hao and Su, Jiacan and Xin, Hongyi and Shi, Weiyang},
title = {Rapid discovery of monoclonal antibodies via high-throughput single BCR affinity sequencing},
journal = {Nucleic Acids Research},
year = {2026},
volume = {54},
number = {15},
doi = {10.1093/nar/gkag789}
}
EUVIMED